-
1
-
-
78049485263
-
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
-
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127:2893-2917.
-
(2010)
Int J Cancer.
, vol.127
, pp. 2893-2917
-
-
Ferlay, J.1
Shin, H.R.2
Bray, F.3
Forman, D.4
Mathers, C.5
Parkin, D.M.6
-
2
-
-
84867048784
-
A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs
-
Peng G, Wang T, Yang KY, Zhang S, Zhang T, Li Q, Han J, Wu G. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 2012; 104:286-293.
-
(2012)
conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol.
, vol.104
, pp. 286-293
-
-
Peng, G.1
Wang, T.2
Yang, K.Y.3
Zhang, S.4
Zhang, T.5
Li, Q.6
Han, J.7
Wu, G.8
-
3
-
-
29244448683
-
Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients
-
Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, Kwong DL, Al-Sarraf M, Chi KH, Hareyama M, Leung SF, Thephamongkhol K, Pignon JP. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys. 2006; 64:47-56.
-
(2006)
Int J Radiat Oncol Biol Phys.
, vol.64
, pp. 47-56
-
-
Baujat, B.1
Audry, H.2
Bourhis, J.3
Chan, A.T.4
Onat, H.5
Chua, D.T.6
Kwong, D.L.7
Al-Sarraf, M.8
Chi, K.H.9
Hareyama, M.10
Leung, S.F.11
Thephamongkhol, K.12
Pignon, J.P.13
-
4
-
-
16544393582
-
The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature
-
Langendijk JA, Leemans CR, Buter J, Berkhof J, Slotman BJ. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol. 2004; 22:4604-4612.
-
(2004)
J Clin Oncol.
, vol.22
, pp. 4604-4612
-
-
Langendijk, J.A.1
Leemans, C.R.2
Buter, J.3
Berkhof, J.4
Slotman, B.J.5
-
5
-
-
0028867420
-
Loss of CTLA-4leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
-
Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995; 3:541-547.
-
(1995)
Immunity.
, vol.3
, pp. 541-547
-
-
Tivol, E.A.1
Borriello, F.2
Schweitzer, A.N.3
Lynch, W.P.4
Bluestone, J.A.5
Sharpe, A.H.6
-
6
-
-
0028791059
-
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4
-
Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science (New York, NY). 1995; 270:985-988.
-
(1995)
Science (New York, NY).
, vol.270
, pp. 985-988
-
-
Waterhouse, P.1
Penninger, J.M.2
Timms, E.3
Wakeham, A.4
Shahinian, A.5
Lee, K.P.6
Thompson, C.B.7
Griesser, H.8
Mak, T.W.9
-
7
-
-
0029899783
-
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells
-
Krummel MF, Allison JP. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med. 1996; 183:2533-2540.
-
(1996)
J Exp Med.
, vol.183
, pp. 2533-2540
-
-
Krummel, M.F.1
Allison, J.P.2
-
8
-
-
0033563271
-
CTLA-4-Mediated inhibition of early events of T cell proliferation
-
Brunner MC, Chambers CA, Chan FK, Hanke J, Winoto A, Allison JP. CTLA-4-Mediated inhibition of early events of T cell proliferation. J Immunol. 1999; 162:5813-5820.
-
(1999)
J Immunol.
, vol.162
, pp. 5813-5820
-
-
Brunner, M.C.1
Chambers, C.A.2
Chan, F.K.3
Hanke, J.4
Winoto, A.5
Allison, J.P.6
-
9
-
-
0033062691
-
CD28/CTLA-4 and CD80/CD86 families: signaling and function
-
Slavik JM, Hutchcroft JE, Bierer BE. CD28/CTLA-4 and CD80/CD86 families: signaling and function. Immunol Res. 1999; 19:1-24.
-
(1999)
Immunol Res.
, vol.19
, pp. 1-24
-
-
Slavik, J.M.1
Hutchcroft, J.E.2
Bierer, B.E.3
-
10
-
-
84866537984
-
Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer
-
Salvi S, Fontana V, Boccardo S, Merlo DF, Margallo E, Laurent S, Morabito A, Rijavec E, Dal Bello MG, Mora M, Ratto GB, Grossi F, Truini M, et al. Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer. Cancer Immunol Immun. 2012; 61:1463-1472.
-
(2012)
Cancer Immunol Immun.
, vol.61
, pp. 1463-1472
-
-
Salvi, S.1
Fontana, V.2
Boccardo, S.3
Merlo, D.F.4
Margallo, E.5
Laurent, S.6
Morabito, A.7
Rijavec, E.8
Dal Bello, M.G.9
Mora, M.10
Ratto, G.B.11
Grossi, F.12
Truini, M.13
-
11
-
-
78649237729
-
New insights of CTLA-4 into its biological function in breast cancer
-
Mao H, Zhang L, Yang Y, Zuo W, Bi Y, Gao W, Deng B, Sun J, Shao Q, Qu X. New insights of CTLA-4 into its biological function in breast cancer. Curr Cancer Drug Tar. 2010; 10:728-736.
-
(2010)
Curr Cancer Drug Tar.
, vol.10
, pp. 728-736
-
-
Mao, H.1
Zhang, L.2
Yang, Y.3
Zuo, W.4
Bi, Y.5
Gao, W.6
Deng, B.7
Sun, J.8
Shao, Q.9
Qu, X.10
-
12
-
-
84880985397
-
Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia
-
Mittal AK, Chaturvedi NK, Rohlfsen RA, Gupta P, Joshi AD, Hegde GV, Bociek RG, Joshi SS. Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia. PloS one. 2013; 8:e70352.
-
(2013)
PloS one.
, vol.8
, pp. e70352
-
-
Mittal, A.K.1
Chaturvedi, N.K.2
Rohlfsen, R.A.3
Gupta, P.4
Joshi, A.D.5
Hegde, G.V.6
Bociek, R.G.7
Joshi, S.S.8
-
13
-
-
80051616648
-
CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment
-
Nair JR, Carlson LM, Koorella C, Rozanski CH, Byrne GE, Bergsagel PL, Shaughnessy JP, Jr., Boise LH, Chanan-Khan A, Lee KP. CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment. J Immunol. 2011; 187:1243-1253.
-
(2011)
J Immunol.
, vol.187
, pp. 1243-1253
-
-
Nair, J.R.1
Carlson, L.M.2
Koorella, C.3
Rozanski, C.H.4
Byrne, G.E.5
Bergsagel, P.L.6
Shaughnessy, J.P.7
Boise, L.H.8
Chanan-Khan, A.9
Lee, K.P.10
-
14
-
-
17344378375
-
CD28, a marker associated with tumoral expansion in multiple myeloma
-
Robillard N, Jego G, Pellat-Deceunynck C, Pineau D, Puthier D, Mellerin MP, Barille S, Rapp MJ, Harousseau JL, Amiot M, Bataille R. CD28, a marker associated with tumoral expansion in multiple myeloma. Clin Cancer Res. 1998; 4:1521-1526.
-
(1998)
Clin Cancer Res.
, vol.4
, pp. 1521-1526
-
-
Robillard, N.1
Jego, G.2
Pellat-Deceunynck, C.3
Pineau, D.4
Puthier, D.5
Mellerin, M.P.6
Barille, S.7
Rapp, M.J.8
Harousseau, J.L.9
Amiot, M.10
Bataille, R.11
-
15
-
-
84909967044
-
Epstein-Barr virus and nasopharyngeal carcinoma
-
Young LS, Dawson CW. Epstein-Barr virus and nasopharyngeal carcinoma. Chin J Cancer. 2014; 33:581-590.
-
(2014)
Chin J Cancer.
, vol.33
, pp. 581-590
-
-
Young, L.S.1
Dawson, C.W.2
-
16
-
-
84951567226
-
Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer
-
Kim JW, Nam KH, Ahn SH, Park DJ, Kim HH, Kim SH, Chang H, Lee JO, Kim YJ, Lee HS, Kim JH, Bang SM, Lee JS, Lee KW. Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer. Gastric Cancer. 2016; 19:42-52. doi: 10.1007/s10120-014-0440-5.
-
(2016)
Gastric Cancer.
, vol.19
, pp. 42-52
-
-
Kim, J.W.1
Nam, K.H.2
Ahn, S.H.3
Park, D.J.4
Kim, H.H.5
Kim, S.H.6
Chang, H.7
Lee, J.O.8
Kim, Y.J.9
Lee, H.S.10
Kim, J.H.11
Bang, S.M.12
Lee, J.S.13
Lee, K.W.14
-
17
-
-
84879599112
-
At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
-
Callahan MK, Wolchok JD. At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy. J Leukoc Biol. 2013; 94:41-53.
-
(2013)
J Leukoc Biol.
, vol.94
, pp. 41-53
-
-
Callahan, M.K.1
Wolchok, J.D.2
-
18
-
-
77249109472
-
Functional polymorphism of cytotoxic T-lymphocyte antigen 4 and nasopharyngeal carcinoma susceptibility in a Chinese population
-
Xiao M, Qi F, Chen X, Luo Z, Zhang L, Zheng C, Hu S, Jiang X, Zhou M, Tang J. Functional polymorphism of cytotoxic T-lymphocyte antigen 4 and nasopharyngeal carcinoma susceptibility in a Chinese population. Int J Immunogent. 2010; 37:27-32.
-
(2010)
Int J Immunogent.
, vol.37
, pp. 27-32
-
-
Xiao, M.1
Qi, F.2
Chen, X.3
Luo, Z.4
Zhang, L.5
Zheng, C.6
Hu, S.7
Jiang, X.8
Zhou, M.9
Tang, J.10
-
20
-
-
0029927713
-
Immunosuppression through blockade of CD28:B7-mediated costimulatory signals
-
Judge TA, Tang A, Turka LA. Immunosuppression through blockade of CD28:B7-mediated costimulatory signals. Immunol Res. 1996; 15:38-49.
-
(1996)
Immunol Res.
, vol.15
, pp. 38-49
-
-
Judge, T.A.1
Tang, A.2
Turka, L.A.3
-
21
-
-
0032787093
-
Impaired expression of CD28 on T cells in hairy cell leukemia
-
van de Corput L, Falkenburg JH, Kester MG, Willemze R, Kluin-Nelemans JC. Impaired expression of CD28 on T cells in hairy cell leukemia. Clin Immunol. 1999; 93:256-262.
-
(1999)
Clin Immunol.
, vol.93
, pp. 256-262
-
-
van de Corput, L.1
Falkenburg, J.H.2
Kester, M.G.3
Willemze, R.4
Kluin-Nelemans, J.C.5
-
22
-
-
0029942655
-
Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia
-
Rossi E, Matutes E, Morilla R, Owusu-Ankomah K, Heffernan AM, Catovsky D. Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia. Leukemia. 1996; 10:494-497.
-
(1996)
Leukemia.
, vol.10
, pp. 494-497
-
-
Rossi, E.1
Matutes, E.2
Morilla, R.3
Owusu-Ankomah, K.4
Heffernan, A.M.5
Catovsky, D.6
-
23
-
-
0035132359
-
Activated T lymphocytes bind in situ to stromal tissue of colon carcinoma but lack adhesion to tumor cells
-
Kruger K, Buning C, Schriever F. Activated T lymphocytes bind in situ to stromal tissue of colon carcinoma but lack adhesion to tumor cells. Eur J Immunol. 2001; 31:138-145.
-
(2001)
Eur J Immunol.
, vol.31
, pp. 138-145
-
-
Kruger, K.1
Buning, C.2
Schriever, F.3
-
24
-
-
84914176287
-
Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma
-
Chan KC. Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma. Chin J Cancer. 2014; 33:598-603.
-
(2014)
Chin J Cancer.
, vol.33
, pp. 598-603
-
-
Chan, K.C.1
-
25
-
-
0037220271
-
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells
-
Pistillo MP, Tazzari PL, Palmisano GL, Pierri I, Bolognesi A, Ferlito F, Capanni P, Polito L, Ratta M, Pileri S, Piccioli M, Basso G, Rissotto L, et al. CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells. Blood. 2003; 101:202-209.
-
(2003)
Blood.
, vol.101
, pp. 202-209
-
-
Pistillo, M.P.1
Tazzari, P.L.2
Palmisano, G.L.3
Pierri, I.4
Bolognesi, A.5
Ferlito, F.6
Capanni, P.7
Polito, L.8
Ratta, M.9
Pileri, S.10
Piccioli, M.11
Basso, G.12
Rissotto, L.13
-
26
-
-
84919767082
-
Diverse mechanisms regulate the surface expression of immunotherapeutic target ctla-4
-
Schneider H, Rudd CE. Diverse mechanisms regulate the surface expression of immunotherapeutic target ctla-4. Front Immunol. 2014; 5:619.
-
(2014)
Front Immunol.
, vol.5
, pp. 619
-
-
Schneider, H.1
Rudd, C.E.2
-
27
-
-
77954801079
-
Improved survival with ipilimumab in patients with metastatic melanoma
-
Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010; 363:711-723.
-
(2010)
N Engl J Med.
, vol.363
, pp. 711-723
-
-
Hodi, F.S.1
O'Day, S.J.2
McDermott, D.F.3
Weber, R.W.4
Sosman, J.A.5
Haanen, J.B.6
Gonzalez, R.7
Robert, C.8
Schadendorf, D.9
Hassel, J.C.10
Akerley, W.11
Van Den Eertwegh, A.J.12
Lutzky, J.13
-
28
-
-
84863911486
-
Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study
-
Lynch TJ, Bondarenko I, Luft A, Serwatowski P, Barlesi F, Chacko R, Sebastian M, Neal J, Lu H, Cuillerot JM, Reck M. Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study. J Clin Oncol. 2012; 30:2046-2054.
-
(2012)
J Clin Oncol.
, vol.30
, pp. 2046-2054
-
-
Lynch, T.J.1
Bondarenko, I.2
Luft, A.3
Serwatowski, P.4
Barlesi, F.5
Chacko, R.6
Sebastian, M.7
Neal, J.8
Lu, H.9
Cuillerot, J.M.10
Reck, M.11
-
29
-
-
84927150740
-
Immune Checkpoint Blockade in Cancer Therapy
-
Postow MA, Callahan MK, Wolchok JD. Immune Checkpoint Blockade in Cancer Therapy. J Clin Oncol. 2015; 33:1974-82. doi: 10.1200/JCO.2014.59.4358.
-
(2015)
J Clin Oncol.
, vol.33
, pp. 1974-1982
-
-
Postow, M.A.1
Callahan, M.K.2
Wolchok, J.D.3
|